got tentative Food and Drug Administration clearance for its antifungal nail lacquer Ciclopirox.
The Allegan, Mich.-based company said that the final approval is subject to expiration of patent for Penlac Nail Lacquer distributed by
, a division of
Penlac, which treats mild to moderate fungal infections of fingernails and toenails, had sales of $125 million for the 12 months ended August. Its patent will expire on Sept. 18, 2007, the company added.
This story was created through a joint venture between TheStreet.com and IRIS.